News FDA Approves New Juvéderm Cosmetic Drug August 3, 2022 Read More » Cimerli August 2, 2022 Read More » Brand Medications with Generic Alternatives Anticipated to be Approved in September August 1, 2022 Read More » Stelara Now Indicated for Psoriatic Arthritis in Children August 1, 2022 Read More » Enhertu August 1, 2022 Read More » Brand Medications with Generic Alternatives Anticipated to be Approved in August July 31, 2022 Read More » Rebinyn Approved to Prevent Hemophilia B Bleeding Episodes July 29, 2022 Read More » New Topical Medication Zoryve Approved for Plaque Psoriasis July 29, 2022 Read More » Benlysta Approved for Younger Lupus Nephritis Patients July 26, 2022 Read More » Page1 … Page25 Page26 Page27 Page28 Page29 … Page41 Benefit Advisors & Employees - Want to know more? Members: Please call the number on the back of your ID card or e-mail member.services@benecardpbf.com Clients: Contact your Client Relations Manager Full Name(Required)Email(Required) Comment(Required)Company Name(Required)CAPTCHA
Brand Medications with Generic Alternatives Anticipated to be Approved in September August 1, 2022 Read More »
Brand Medications with Generic Alternatives Anticipated to be Approved in August July 31, 2022 Read More »